Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Appliance of science

- PMLiVE

Pandemic readiness is now a financial risk test – and the UK must treat it that way

COVID-19 showed how quickly a health emergency becomes a fiscal event: disrupting supply chains, reshaping capital allocation and exposing governance weaknesses

- PMLiVE

What HCPs want from digital pharma in 2026: The value gap

We’re proud to share Graphite’s 2026 research report. An in-depth look at how healthcare professionals experience digital engagement with life sciences today, and where the value gap is widening.

Graphite Digital

- PMLiVE

The Greatest Form of Caring: Medscape’s Commitment to Advancing Cardiovascular Health

A February Focus on the Heart  While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health....

Medscape Education

- PMLiVE

AI, Agility, and Connected Impact at Alliance 2026

Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in...

Medscape Education

- PMLiVE

Putting AI to work for pharma marketing leaders of the future

Modern marketing is a hybrid craft, built on human judgement and empathy, strengthened by AI’s ability to work at scale and analyse complex information

- PMLiVE

Bayer launches ‘Anything but Normal’ campaign highlighting women’s health issues

Over 1.5 billion women worldwide – almost one in two women – experience women’s health issues

- PMLiVE

LEO Pharma’s Anzupgo cream progresses to phase 3 trial for lichen sclerosus

There are currently no approved treatments specifically indicated for LS in the US or Europe

- PMLiVE

ViCentra appoints Reman McDonagh as Vice President, Global Marketing

McDonagh has held senior leadership positions at Roche, Medtronic, Cellnovo and Insulet

- PMLiVE

Designing healthcare AI that works for every patient

As generative AI becomes more embedded in clinical decision-making, ensuring safety, accuracy and relevance is critical

- PMLiVE

Novo Nordisk announces positive results for CagriSema in type 2 diabetes

CagriSema improved weight loss and blood glucose control compared to semaglutide alone across all tested doses

- PMLiVE

TECregen appoints Klaas P Zuideveld as CEO

Zuideveld was most recently CEO of Versameb, and has held senior roles at Caris Life Sciences and Roche

- PMLiVE

Shaping the future of healthcare communications

Introducing the 2026 Communiqué Awards

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links